Product NDC: | 68516-5214 |
Proprietary Name: | Albutein |
Non Proprietary Name: | Albumin (Human) |
Active Ingredient(s): | 12.5 g/250mL & nbsp; Albumin (Human) |
Administration Route(s): | INTRAVENOUS |
Dosage Form(s): | INJECTION, SOLUTION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 68516-5214 |
Labeler Name: | Grifols Biologicals Inc. |
Product Type: | PLASMA DERIVATIVE |
FDA Application Number: | BLA102478 |
Marketing Category: | BLA |
Start Marketing Date: | 19780815 |
Package NDC: | 68516-5214-1 |
Package Description: | 1 VIAL in 1 CARTON (68516-5214-1) > 250 mL in 1 VIAL (68516-5214-3) |
NDC Code | 68516-5214-1 |
Proprietary Name | Albutein |
Package Description | 1 VIAL in 1 CARTON (68516-5214-1) > 250 mL in 1 VIAL (68516-5214-3) |
Product NDC | 68516-5214 |
Product Type Name | PLASMA DERIVATIVE |
Non Proprietary Name | Albumin (Human) |
Dosage Form Name | INJECTION, SOLUTION |
Route Name | INTRAVENOUS |
Start Marketing Date | 19780815 |
Marketing Category Name | BLA |
Labeler Name | Grifols Biologicals Inc. |
Substance Name | ALBUMIN (HUMAN) |
Strength Number | 12.5 |
Strength Unit | g/250mL |
Pharmaceutical Classes | Human Serum Albumin [EPC],Increased Intravascular Volume [PE],Increased Oncotic Pressure [PE],Osmotic Activity [MoA],Serum Albumin [Chemical/Ingredient] |